# Bridging for Drug-Device and Biologic-Device Combination Products: Draft  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/bridging-for-drug-device-and-biologic-device-combination-products-draft-guidance-for-industry/b906c8bd-9549-44b2-903e-95838dcc4ec3

> FDA guidance document: Bridging for Drug-Device and Biologic-Device Combination Products: Draft  Guidance for Industry. Issue date: December 19, 2019. Get complete insights and analysis.

---

## Details

- Title: Bridging for Drug-Device and Biologic-Device Combination Products: Draft  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2019-12-19
- Comment Close Date: 2020-02-18
- Last Changed: 2020-07-06
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2019-D-5585">FDA-2019-D-5585</a>

## Related Documents

- [Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/myelodysplastic-syndromes-developing-drug-and-biological-products-for-treatment-draft-guidance-for-industry/4c1a6b62-5c53-485e-9004-1b388e3f1bf3)
- [Graft-versus-Host Diseases: Developing Drugs, Biological Products, and Certain Devices for Prevention or Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/graft-versus-host-diseases-developing-drugs-biological-products-and-certain-devices-for-prevention-or-treatment/30eba576-b6ea-4536-918e-e634aefadcc4)
- [ICH Q12: Implementation Considerations for FDA-Regulated Products: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/ich-q12-implementation-considerations-for-fda-regulated-products-draft-guidance-for-industry/2c7d4c33-4495-4c29-abb1-22058de23404)